Have a feature idea you'd love to see implemented?
Let us know!
INDV Indivior Plc
Price (delayed)
$10.76
Market cap
$1.48B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.02
Enterprise value
$1.48B
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline
Highlights
The EPS has soared by 99% YoY and by 98% from the previous quarter
The net income has surged by 99% year-on-year and by 99% since the previous quarter
The equity has contracted by 38% from the previous quarter
The quick ratio has contracted by 24% YoY and by 6% from the previous quarter
Key stats
What are the main financial stats of INDV
Market
Valuations
Earnings
Shares outstanding
137.94M
Market cap
$1.48B
Enterprise value
$1.48B
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.22
EV/EBIT
56.93
EV/EBITDA
27.41
EV/Sales
1.25
Revenue
$1.18B
EBIT
$26M
EBITDA
$54M
Free cash flow
-$345M
Per share
Balance sheet
Liquidity
EPS
-$0.02
Free cash flow per share
-$2.57
Book value per share
-$1.25
Revenue per share
$8.83
TBVPS
$9.51
Total assets
$1.46B
Total liabilities
$1.63B
Debt
$284M
Equity
-$167M
Working capital
-$163M
Debt to equity
-1.7
Current ratio
0.83
Quick ratio
0.59
Net debt/EBITDA
-0.07
Margins
Efficiency
Dividend
EBITDA margin
4.6%
Gross margin
78.1%
Net margin
-0.2%
Operating margin
-0.2%
Return on assets
-0.1%
Return on equity
N/A
Return on invested capital
7.7%
Return on capital employed
5.2%
Return on sales
2.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INDV stock price
How has the Indivior stock price performed over time
Intraday
1.7%
1 week
6.01%
1 month
30.11%
1 year
-36.67%
YTD
-29.54%
QTD
10.36%
Financial performance
How have Indivior's revenue and profit performed over time
Revenue
$1.18B
Gross profit
$924M
Operating income
-$2M
Net income
-$2M
Gross margin
78.1%
Net margin
-0.2%
The operating income has surged by 99% year-on-year and by 99% since the previous quarter
INDV's operating margin has surged by 99% year-on-year and by 99% since the previous quarter
Indivior's net margin has soared by 99% YoY and by 98% from the previous quarter
The net income has surged by 99% year-on-year and by 99% since the previous quarter
Growth
What is Indivior's growth rate over time
Valuation
What is Indivior stock price valuation
P/E
N/A
P/B
N/A
P/S
1.22
EV/EBIT
56.93
EV/EBITDA
27.41
EV/Sales
1.25
The EPS has soared by 99% YoY and by 98% from the previous quarter
The equity has contracted by 38% from the previous quarter
The stock's price to sales (P/S) is 36% less than its last 4 quarters average of 1.9
INDV's revenue is up by 14% year-on-year and by 3.1% since the previous quarter
Efficiency
How efficient is Indivior business performance
The ROS has soared by 116% from the previous quarter and by 108% YoY
Indivior's return on invested capital has surged by 114% QoQ and by 105% YoY
Indivior's ROA has soared by 99% YoY and by 99% from the previous quarter
Dividends
What is INDV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INDV.
Financial health
How did Indivior financials performed over time
Indivior's total assets is 10% lower than its total liabilities
The quick ratio has contracted by 24% YoY and by 6% from the previous quarter
Indivior's total assets has decreased by 21% YoY and by 4.6% QoQ
The debt to equity has soared by 85% year-on-year and by 27% since the previous quarter
The equity has contracted by 38% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.